Capecitabine(卡培他滨 )是一种新的口服氟嘧啶类抗肿瘤药 ,具有选择性的抗肿瘤活性。近年来国外研究表明 ,Capecitabine对于蒽环类、紫杉醇和 (或 )多种化疗药耐药的局部晚期或复发转移乳腺癌有较好的疗效。对正常组织损伤小 ,全身毒副作用轻 ,患者耐受良好 ,有较高的生活质量 ,用药经济、方便 ,是一种有前途的抗肿瘤药 Capecitabine is a new oral fluoropyrimidine antineoplastic agent with selective antitumor activity. In recent years, foreign studies have shown that Capecitabine for anthracyclines, paclitaxel and (or) a variety of chemotherapeutic drugs resistant locally advanced or recurrent metastatic breast cancer has a good effect. Small damage to normal tissue, systemic side effects, patients with good tolerance, high quality of life, medication economy, convenience, is a promising antineoplastic